In the cases of weight loss and erectile dysfunction, more patients are getting the care they want or need. I personally ...

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...

Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. M ore than one in sev ...

Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...

As part of an investigation that dates back to 2023, the FDA has identified over two dozen products featuring the plant.

Consumers are paying in cash in a hotly competitive marketplace, creating a rare phenomenon for a relatively new class of prescription drugs: falling prices.

Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities.

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...